Show results for
Refine by
Clinically Studied Software In France
8 software items found
by:Novatek International based inMontreal, QUEBEC (CANADA)
In clinical studies, assessing and managing risks, as well as establishing areas of uncertainty that contribute to risk, are critical to a company’s decision making processes. Many business units within pharmaceutical, biotechnology and clinical research organizations must comply with federal regulations concerning their processes and ...
by:Novadiscovery based inLyon, FRANCE
The JINKO platform is NOVA’s unified in silico clinical trial simulation platform With Artificial Intelligence and virtual populations at the heart of NOVA's innovative approach, the platform takes its name from the fortunate homonymic collision of the Japanese words for ‘artificial’ and ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Cardiac diseases are the #1 cause of death globally1,2. Genetic testing is frequently considered a key component of the clinical management process of inherited cardiac disorders, such as hypertrophic, dilated, and arrhythmogenic cardiomyopathies, aortopathies, and inherited arrhythmia syndromes3. This approach is typically reserved for patients with a confirmed or suspected diagnosis of an ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Alamut Visual Plus™ enables deep assessment of variants on a genomic scale, empowering clinical researchers to make accurate decisions for their data interpretation. Alamut Visual Plus™ is a full genome browser designed to help researchers investigate variations of the human genome. The software combines a wide set of external data with high-quality missense and splicing predictors in ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Maximize your biologically actionable insights from small tumor samples with the SOPHiA DDM™ RNAtarget Technology end-to-end solutions. Gene fusions have been associated with various tumors and are recognized as valuable cancer biomarkers in cancer research1. Targeted RNA sequencing is recommended to maximize novel fusion detection by identifying transcribed and potentially actionable ...
by:Qynapse based inParis, FRANCE
QyScore is a groundbreaking neuroimaging analysis platform for both clinical routine and clinical trial settings. One scan at a time, QyScore has the potential to revolutionize the treatment of CNS disease and create the potential for earlier precision on the frontlines of CNS disease. QyScore is intended for automatic labeling, visualization and volumetric quantification of segmentable brain ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Deeper genomic insights, fewer missed opportunities. CGP enables clinical researchers to identify actionable variants and biomarkers across hundreds of genes using a single solution. The SOPHiA DDMTM Platform offers decentralized, in-house next generation sequencing (NGS) applications that help maximize insights from CGP data by leveraging advanced analytical capabilities, intutive interpretation ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Enabling novel fusion detection in small samples to improve lung cancer management. Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a CE-marked in vitro diagnostic (IVD) application based on next-generation sequencing (NGS) enabling accurate and sensitive detection of novel ...